Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection
Offer reference number: CM/PHG/22/5694
FIND A TENDER (FTS) - 2023/S 000-001392
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/22/5694/00 - Dasatinib
CESW 01/05/2023 - 30/04/2024 - (12 Months)
LSNE 01/05/2023 - 30/04/2024 - (12 Months)
NWLN 01/05/2023 - 30/04/2024 - (12 Months)
CM/PHG/22/5694/01 - Paliperidone Injection:
LSNE 01/05/2023 - 31/05/2024 (13 Months)
NWLN 01/05/2023 - 31/01/2025 (21 months)
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Janssen-Cilag Ltd | 01027904 | ~£27,009,807 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Mercury Pharmaceuticals Limited | 02619880 | ~£27,009,807 estimated from lot values | - |
| Mylan | 05460854 | ~£27,009,807 estimated from lot values | - |
| Teva UK Limited | 00302461 | ~£27,009,807 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£27,009,807 estimated from lot values | - |
Government spending data: These suppliers have received £127,859,347 in 1,399 payments (over £25k) from Department of Health and Social Care, Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust, Worcestershire Acute Hospitals NHS Trust, United Lincolnshire Hospitals NHS Trust and 15 more public bodies (2010-04-28 to 2026-03-31).